naphazoline hydrochloride and pheniramine maleate · NAPHAZOLINE HYDROCHLORIDE .25 mg/mL; PHENIRAMINE MALEATE 3 mg/mL · Solution/ Drops · Ophthalmic · Alcon Laboratories, Inc.
NDC 00065-0085-15 · 1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE · NDA · View full market →
5 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.5590 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.
Some pressure is visible, but not much — here’s everything the score found to count.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market · price up 1% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bausch & Lomb Incorporated | NAPHAZOLINE HYDROCHLORIDE .2675 mg/mL; PHENIRAMINE MALEATE 3.15 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | NAPHAZOLINE HYDROCHLORIDE .25 mg/mL; PHENIRAMINE MALEATE 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alcon Laboratories, Inc. | NAPHAZOLINE HYDROCHLORIDE .25 mg/mL; PHENIRAMINE MALEATE 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cvs Pharmacy | NAPHAZOLINE HYDROCHLORIDE .2675 mg/mL; PHENIRAMINE MALEATE 3.15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Kenvue Brands LLC | NAPHAZOLINE HYDROCHLORIDE .25 mg/mL; PHENIRAMINE MALEATE 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Naphcon A — NDC 00065-0085-15," retrieved September 3, 2026, https://drugdashboards.com/drug/00065008515.
Free to cite with attribution — see how the data is put together.